Table 2 Laboratory findings of patients at admission.

From: Elevated troponin levels in rhabdomyolysis as a predictor of mortality in patients with normal kidney and cardiac function

Parameter

Negative troponin* (N = 100)

Positive troponin (N = 152)

Total cohort

P-value

Haemoglobin (mg/dl), mean ± SD

13.81 ± 1.43

12.15 ± 1.65

12.79 ± 1.76

P < 0.0001

Platelet (mg/dl), mean ± SD

219.53 ± 60.79

227.22 ± 77.43

224.27 ± 71.47

P = 0.4912

WBC† (mg/dl), mean ± SD

7.54 ± 2.81

9.18 ± 2.58

8.55 ± 2.78

P < 0.0001

Urea (mg/dl), mean ± SD

26.37 ± 10.89

52.72 ± 34.33

42.26 ± 30.37

P < 0.0001

Albumin (mg/dl), mean ± SD

4.18 ± 0.39

3.57 ± 0.5

3.81 ± 0.55

P < 0.0001

Creatinine (mg/dl), mean ± SD

0.85 ± 0.20

1.17 ± 1.24

1.04 ± 0.98

P < 0.01

Initial troponin (mg/dl), mean ± SD

0

106 ± 156.9

64.52 ± 132.5

P < 0.0001

Initial CPK‡ (mg/dl), median (IQR)

6346 (3017–15420)

3623 (1635–7267)

4292 (1931–9624)

P < 0.001

Maximal CPK‡ levels median (IQR) (mg/dl)

6628 (3143–15758)

4411 (1932–9692)

5478 (2259–12254)

P < 0.01

  1. Normally distributed continuous variables are presented as mean ± SD; non-normally distributed variables are presented as medians and IQR. *Negative troponin is defined as high-sensitivity cardiac troponin I < 15ng/L; †WBC, white blood cell; ‡CPK, creatine phosphokinase.
Back to article page